Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
about
Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsRole of platelets in neuroinflammation: a wide-angle perspectiveDaclizumab treatment for multiple sclerosis.Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy.Venous endothelial injury in central nervous system diseasesEfficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophySynthesis and antibacterial activity of doxycycline neoglycosides.Current and future therapies for multiple sclerosis.Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.Alemtuzumab and multiple sclerosis: therapeutic application.Update on the treatment options for multiple sclerosis.Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.Oral doxycycline for the prevention of postoperative trachomatous trichiasis in Ethiopia: a randomised, double-blind, placebo-controlled trial.
P2860
Q24631610-28B3F7E0-1E6B-494E-B8E7-05525E658301Q28393808-D913865F-B593-40D2-883F-BA5CF2ADB19AQ33382919-D25E5B7A-DC83-4DA0-A037-87CAA29B443DQ35030852-2A3DF686-8E7B-4E7E-BC0E-B60D5D7413FFQ35042424-FE13C910-49E2-4A4A-BD5C-6389DFD194B0Q35843863-336E65F0-63DE-4348-9035-311F2F1BED18Q37091285-3C94F9A1-A3FE-4FFB-B465-95D0D6D0529FQ37270510-A8E1D5AC-72ED-45CD-B94E-F6BB7A2AC736Q37287769-FC8CFE49-E1C0-47A7-888C-4D5BBFBB58C6Q37311605-B3DF01C3-5D3B-4027-97C6-302658C7F60DQ37679919-EE6D591B-29BA-44A7-A4E7-BF0AA49A75C6Q37729045-2023ED79-A6BD-4FA6-AB75-0F36CDCD5DB8Q38029187-49D5A9A8-546D-4B82-A728-956578745732Q38870841-EC270CE2-758A-44C0-AD78-E4E7439944C2Q39031301-F378FCB2-75DB-4421-A900-96B54714398FQ40020998-15D8E8B0-6123-4089-9280-A35F3D9E311CQ46588473-63FC878F-A6A2-4B2B-ABFA-D4C1B8E5D58EQ48132175-CD675B0E-35CE-480E-BE3D-5CE817E18AF6Q48232899-FB4E8121-7606-4EF1-BB4D-AFA15036B6FEQ52591499-692F9F93-5B64-44E7-BA2C-DC682D87956FQ53693112-5424418A-1D06-4E0B-AAB9-5BDA4F943F20
P2860
Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Combination therapy with inter ...... clerosis: an open-label trial.
@en
type
label
Combination therapy with inter ...... clerosis: an open-label trial.
@en
prefLabel
Combination therapy with inter ...... clerosis: an open-label trial.
@en
P2093
P1433
P1476
Combination therapy with inter ...... clerosis: an open-label trial.
@en
P2093
Alireza Minagar
Eduardo Gonzalez-Toledo
J Steven Alexander
Joaquim J Jimenez
Lucia Mauro
Robert N Schwendimann
Roger E Kelley
Stacy J Smith
P304
P356
10.1001/ARCHNEUROL.2007.41
P577
2007-12-10T00:00:00Z